Want to see SG:8YY full AI Analyst Report?
Total Valuation
Biolidics Ltd. has a market cap or net worth of S$62.40M. The enterprise value is S$74.41.
Market CapS$62.40M
Enterprise ValueS$74.41
Share Statistics
Biolidics Ltd. has 1,733,441,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,733,441,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biolidics Ltd.’s return on equity (ROE) is -2.59 and return on invested capital (ROIC) is -75.44%.
Return on Equity (ROE)-2.59
Return on Assets (ROA)-0.78
Return on Invested Capital (ROIC)-75.44%
Return on Capital Employed (ROCE)-0.81
Revenue Per Employee328.69K
Profits Per Employee-249.63K
Employee Count16
Asset Turnover1.04
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Biolidics Ltd. is ―. Biolidics Ltd.’s PEG ratio is 0.66.
PE Ratio―
PS Ratio16.93
PB Ratio58.30
Price to Fair Value58.30
Price to FCF-247.30
Price to Operating Cash Flow154.38
PEG Ratio0.66
Income Statement
In the last 12 months, Biolidics Ltd. had revenue of 5.26M and earned -3.96M in profits. Earnings per share was >-0.01.
Revenue5.26M
Gross Profit1.94M
Operating Income-3.22M
Pretax Income-3.99M
Net Income-3.96M
EBITDA-3.65M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 393.00K and capital expenditures -2.00K, giving a free cash flow of 391.00K billion.
Operating Cash Flow393.00K
Free Cash Flow391.00K
Free Cash Flow per Share<0.01
Dividends & Yields
Biolidics Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.55
52-Week Price Change40.00%
50-Day Moving Average0.04
200-Day Moving Average0.05
Relative Strength Index (RSI)57.19
Average Volume (3m)254.46K
Important Dates
Biolidics Ltd. upcoming earnings date is Nov 4, 2026, TBA (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 4, 2026
Ex-Dividend Date―
Financial Position
Biolidics Ltd. as a current ratio of 1.17, with Debt / Equity ratio of 151.25%
Current Ratio1.17
Quick Ratio1.17
Debt to Market Cap0.03
Net Debt to EBITDA-0.51
Interest Coverage Ratio-40.27
Taxes
In the past 12 months, Biolidics Ltd. has paid -29.00K in taxes.
Income Tax-29.00K
Effective Tax Rate<0.01
Enterprise Valuation
Biolidics Ltd. EV to EBITDA ratio is -24.89, with an EV/FCF ratio of -252.46.
EV to Sales17.28
EV to EBITDA-24.89
EV to Free Cash Flow-252.46
EV to Operating Cash Flow-252.46
Balance Sheet
Biolidics Ltd. has S$494.00K in cash and marketable securities with S$2.77M in debt, giving a net cash position of -S$2.28M billion.
Cash & Marketable SecuritiesS$494.00K
Total DebtS$2.77M
Net Cash-S$2.28M
Net Cash Per Share>-S$0.01
Tangible Book Value Per Share>-S$0.01
Margins
Gross margin is 30.65%, with operating margin of -61.27%, and net profit margin of -75.34%.
Gross Margin30.65%
Operating Margin-61.27%
Pretax Margin-75.95%
Net Profit Margin-75.34%
EBITDA Margin-69.42%
EBIT Margin-74.42%
Analyst Forecast
The average price target for Biolidics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―